EG vs SPNT: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
EG is the larger of the two ($15.95B market cap): the incumbent the market prices for continued execution (7.08x forward earnings, beta 0.23). SPNT is the smaller challenger ($3.08B), actually pricier on forward earnings (9.77x): more room to run, but more to prove. If you believe SPNT earns its premium (9.77x forward earnings, so the market expects more from it), SPNT fits. If you believe in paying less for profit, EG fits at 7.08x.
EG vs SPNT: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | EG | SPNT | What it tells you |
|---|---|---|---|
| Market cap | $15.95B | $3.08B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 7.08 | 9.77 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 9.05 | 6.58 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.23 | 0.57 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 95% of range | 91% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.13 | 1.38 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: EG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how EG and SPNT affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EG and SPNT share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EG and SPNT exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Everest Group (EG) do?
Everest Group is a global property and casualty insurance and reinsurance company. Formerly Everest Re Group, it operates two main businesses: reinsurance, where it provides coverage to other insurance companies to help them manage large or catastrophic risks, and primary insurance, where it underwrites commercial property and casualty, specialty, and other lines directly for businesses. Reinsurance is its larger and historically core operation, spanning property catastrophe, casualty, and specialty treaties placed with insurers worldwide. Everest makes money in two ways: underwriting profit, the premiums it collects minus the claims and expenses it pays, and investment income earned on the large pool of premiums (the float) it holds before claims are paid. The company is known for disciplined underwriting and the ability to deploy or pull back capacity as pricing cycles shift, leaning into reinsurance when rates harden and reducing exposure when they soften. Everest is domiciled in Bermuda with significant US operations and is a member of the S&P 500.
What does SiriusPoint Ltd. (SPNT) do?
SiriusPoint was formed in 2021 when Third Point Reinsurance merged with Sirius International Insurance Group, and it now writes roughly $3.8 billion of gross premium a year across two segments, Insurance & Services and Reinsurance. The book spans about ten lines of business from four underwriting hubs, with accident and health the largest at roughly 27 percent of premium and general liability next at about 21 percent, and no other line above 10 percent. Alongside the underwriting operation sits International Medical Group, a travel and medical MGA that has been adding capability through bolt-on deals including Assist America in late 2025 and the World Nomads brand in early 2026. Headquarters are in Bermuda, staff numbers roughly 1,000, and the NYSE listing is the company's primary and only US listing.
EG vs SPNT: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- EG drivers: Hard reinsurance pricing; Investment income tailwind.
- SPNT drivers: Specialty insurance replacing reinsurance in the mix; Underwriting margin, not premium growth.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: As a property and casualty reinsurer, Everest is exposed to large, unpredictable catastrophe losses from hurricanes, earthquakes, wildfires, and other events, which can cause sharp earnings swings or losses in bad years. For SPNT, catastrophe and large-loss exposure has not disappeared, and a single heavy wind or wildfire season can erase a year of underwriting margin at a company of this size.
EG or SPNT: which should you pick?
If the story you believe is EG's (Hard reinsurance pricing), EG is the more direct way to own it; if it is SPNT's (Specialty insurance replacing reinsurance in the mix), SPNT is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EG and SPNT guides.
EG vs SPNT: the full fundamentals
EG. Everest now trades a little above book value at about 1.13x and about 7x forward earnings, still low in absolute terms for property and casualty reinsurers whose earnings are volatile and catastrophe-exposed, but well above the sub-book level it held in October. The market values it on book-value growth, combined ratio, and return on equity through the cycle; a hurricane-season quarter that roughly matched the prior year removed one worry, while shrinking premium volume remains the main debate. The average analyst target of about $438 sits close to the current price.
SPNT. At about $26.74 the shares change hands near 1.3 times book value per diluted share ex-AOCI (about 1.4 times on Yahoo Finance's reported book), a modest premium for a carrier earning a mid-to-high-teens operating return. The trailing price to earnings ratio of roughly 6.6 is not a clean read, because trailing net income of about $495 million includes gains that will not recur; the forward multiple sits near 9.8 on consensus 2027 EPS of about $2.74, after about $2.82 expected for 2026. For an insurer, growth in book value per share plus capital returned is generally the more informative measure, and book value ex-AOCI rose 4 percent in the third quarter alone. The four-analyst mean target is about $30.25.
Headline figures (approximate, November 2026): EG shows revenue (ttm) ~$16.2 billion (down ~14% YoY in latest quarter), net income (ttm) ~$1.87 billion, q3 2026 operating eps $7.62 vs ~$7.97 estimate, p/e (trailing / forward) ~9x / ~7x; SPNT shows core gross premiums written (q3 2026) ~$991M, up ~13.7% YoY, revenue (ttm) ~$3.1B; Q3 2026 revenue ~$868M, up ~16.5% YoY, net income (ttm) ~$495M (includes non-recurring gains); Q3 2026 operating EPS $0.88 vs ~$0.64 expected, core combined ratio (q3 2026) ~90.1%.
The bottom line: EG vs SPNT
EG and SPNT are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined EG and SPNT exposure against your real portfolio. It is not an investment adviser.
Wondering how EG or SPNT fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Everest Group
Ask Walnut's AI anything about EG and see how it fits what you own.
FAQ
What is the difference between EG and SPNT?
+
Everest Group is a global property and casualty insurance and reinsurance company. SiriusPoint was formed in 2021 when Third Point Reinsurance merged with Sirius International Insurance Group, and it now writes roughly $3.8 billion of gross premium a year across two segments, Insurance & Services and Reinsurance. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is EG or SPNT the better stock?
+
Neither is universally better. EG is the larger incumbent; SPNT is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, EG or SPNT?
+
On forward P/E (as of November 2026), EG trades at 7.08x and SPNT at 9.77x, so EG is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both EG and SPNT?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of EG vs SPNT?
+
EG: As a property and casualty reinsurer, Everest is exposed to large, unpredictable catastrophe losses from hurricanes, earthquakes, wildfires, and other events, which can cause sharp earnings swings or losses in bad years. Reinsurance pricing is cyclical, and a softening market would pressure margins and returns. The company faces reserve risk if claims develop worse than expected, particularly in long-tail casualty lines, and it has taken reserve charges that hurt results. Its large investment portfolio carries interest-rate and credit risk. Climate change may increase the frequency and severity of catastrophes, and the stock can be volatile around major loss events and reserve actions. The third quarter is the heart of the North Atlantic hurricane season, and the Q3 2025 result (EPS of $7.54 versus an estimate near $14.52) showed how far a single quarter can miss, and Q3 2026 (EPS of $7.62 versus about $7.97) was again the weakest quarter of the year. Shrinking revenue also leaves less premium to spread fixed costs across if pricing softens further, and after a 41 percent one-year gain the shares now trade above book value, so a loss event has less valuation cushion than it did in October. SPNT: Catastrophe and large-loss exposure has not disappeared, and a single heavy wind or wildfire season can erase a year of underwriting margin at a company of this size. Reserve development is the second exposure: the current streak of favorable releases is a strength today and a comparison problem later, since a company cannot release reserves indefinitely. Pricing across property catastrophe and much of casualty reinsurance has been drifting lower, which is precisely why premium is falling in that segment, and a longer soft market would pressure the 12 to 15 percent operating return target. Ownership is concentrated enough to matter, with entities associated with Daniel Loeb holding roughly 9.5 percent, and take-private speculation has circulated around the name before without a transaction ever being signed. The share price itself has moved: at about $26.74 on November 20, 2026 the stock sits near the top of its 52-week range of roughly $19.15 to $27.55, so less of the turnaround is left unpriced than a year ago. Analysts expect fourth-quarter EPS of about $0.58, down about 17% year over year, and 2027 EPS of about $2.74, slightly below 2026's expected $2.82. The RiverStone loss portfolio transfer still needs regulatory approval, and the capital it frees has not yet been allocated. Finally, the trailing headline earnings multiple near 6.6 times is flattered by non-recurring items including asset sales, so anyone anchoring on it is looking at a number the operating business does not repeat.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell EG or SPNT; figures are approximate and dated (as of November 2026). Verify current data before investing.